221 related articles for article (PubMed ID: 14751531)
1. A bispecific antibody to enhance radiotherapy by tumor necrosis factor-alpha in human CEA-expressing digestive tumors.
Azria D; Larbouret C; Garambois V; Gourgou S; Martineau P; Robert B; Dubois JB; Pelegrin A
Int J Radiat Oncol Biol Phys; 2004 Feb; 58(2):580-8. PubMed ID: 14751531
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of radiation therapy by tumor necrosis factor alpha in human colon cancer using a bispecific antibody.
Azria D; Dorvillius M; Gourgou S; Martineau P; Robert B; Pugnière M; Delard R; Ychou M; Dubois JB; Pèlegrin A
Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1363-73. PubMed ID: 12654449
[TBL] [Abstract][Full Text] [Related]
3. Radiocurability by targeting tumor necrosis factor-alpha using a bispecific antibody in carcinoembryonic antigen transgenic mice.
Larbouret C; Robert B; Linard C; Teulon I; Gourgou S; Bibeau F; Martineau P; Santoro L; Pouget JP; Pelegrin A; Azria D
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1231-7. PubMed ID: 17967312
[TBL] [Abstract][Full Text] [Related]
4. Cytokine targeting in tumors using a bispecific antibody directed against carcinoembryonic antigen and tumor necrosis factor alpha.
Robert B; Mach JP; Mani JC; Ychou M; Folli S; Artus JC; Pèlegrin A
Cancer Res; 1996 Oct; 56(20):4758-65. PubMed ID: 8840995
[TBL] [Abstract][Full Text] [Related]
5. Liposome-encapsulated tumor necrosis factor-alpha enhances the effects of radiation against human colon tumor xenografts.
Kim DW; Andres ML; Li J; Kajioka EH; Miller GM; Seynhaeve AL; Ten Hagen TL; Gridley DS
J Interferon Cytokine Res; 2001 Nov; 21(11):885-97. PubMed ID: 11747620
[TBL] [Abstract][Full Text] [Related]
6. Potentiation of ionising radiation by targeting tumour necrosis factor alpha using a bispecific antibody in human pancreatic cancer.
Azria D; Larbouret C; Garambois V; Kramar A; Martineau P; Robert B; Aillères N; Ychou M; Dubois JB; Pèlegrin A
Br J Cancer; 2003 Nov; 89(10):1987-94. PubMed ID: 14612914
[TBL] [Abstract][Full Text] [Related]
7. Targeting of human breast cancer by a bispecific antibody directed against two tumour-associated antigens: ErbB-2 and carcinoembryonic antigen.
Dorvillius M; Garambois V; Pourquier D; Gutowski M; Rouanet P; Mani JC; Pugnière M; Hynes NE; Pèlegrin A
Tumour Biol; 2002; 23(6):337-47. PubMed ID: 12677091
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor-alpha augments radiation effects against human colon tumor xenografts.
Gridley DS; Hammond SN; Liwnicz BH
Anticancer Res; 1994; 14(3A):1107-12. PubMed ID: 8074459
[TBL] [Abstract][Full Text] [Related]
9. α- Versus β-Emitting Radionuclides for Pretargeted Radioimmunotherapy of Carcinoembryonic Antigen-Expressing Human Colon Cancer Xenografts.
Heskamp S; Hernandez R; Molkenboer-Kuenen JDM; Essler M; Bruchertseifer F; Morgenstern A; Steenbergen EJ; Cai W; Seidl C; McBride WJ; Goldenberg DM; Boerman OC
J Nucl Med; 2017 Jun; 58(6):926-933. PubMed ID: 28232604
[TBL] [Abstract][Full Text] [Related]
10. Combined radioimmunotherapy and radiotherapy of human colon carcinoma grafted in nude mice.
Buchegger F; Rojas A; Delaloye AB; Vogel CA; Mirimanoff RO; Coucke P; Sun LQ; Raimondi S; Denekamp J; Pèlgrin A
Cancer Res; 1995 Jan; 55(1):83-9. PubMed ID: 7805046
[TBL] [Abstract][Full Text] [Related]
11. Immunohistology of carcinoembryonic antigen (CEA)-expressing tumors grafted in nude mice after radioimmunotherapy with 131I-labeled bivalent hapten and anti-CEA x antihapten bispecific antibody.
Gautherot E; Kraeber-Bodéré F; Daniel L; Fiche M; Rouvier E; Saï-Maurel C; Thedrez P; Chatal JF; Barbet J
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3177s-3182s. PubMed ID: 10541361
[TBL] [Abstract][Full Text] [Related]
12. Tumor-necrosis factor can enhance radio-antibody uptake in human colon carcinoma xenografts by increasing vascular permeability.
Folli S; Pèlegrin A; Chalandon Y; Yao X; Buchegger F; Lienard D; Lejeune F; Mach JP
Int J Cancer; 1993 Mar; 53(5):829-36. PubMed ID: 8449608
[TBL] [Abstract][Full Text] [Related]
13. Bispecific antibody targeting of doxorubicin to carcinoembryonic antigen-expressing colon cancer cell lines in vitro and in vivo.
Ford CH; Osborne PA; Rego BG; Mathew A
Int J Cancer; 2001 Jun; 92(6):851-5. PubMed ID: 11351306
[TBL] [Abstract][Full Text] [Related]
14. Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide.
Ning S; Knox SJ
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):197-203. PubMed ID: 15337556
[TBL] [Abstract][Full Text] [Related]
15. The effect of combining recombinant human tumor necrosis factor-alpha with local radiation on tumor control probability of a human glioblastoma multiforme xenograft in nude mice.
Huang P; Allam A; Perez LA; Taghian A; Freeman J; Suit HD
Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):93-8. PubMed ID: 7721643
[TBL] [Abstract][Full Text] [Related]
16. Near infra-red photoimmunotherapy with anti-CEA-IR700 results in extensive tumor lysis and a significant decrease in tumor burden in orthotopic mouse models of pancreatic cancer.
Maawy AA; Hiroshima Y; Zhang Y; Heim R; Makings L; Garcia-Guzman M; Luiken GA; Kobayashi H; Hoffman RM; Bouvet M
PLoS One; 2015; 10(3):e0121989. PubMed ID: 25799218
[TBL] [Abstract][Full Text] [Related]
17. Radiobiologic studies of radioimmunotherapy and external beam radiotherapy in vitro and in vivo in human renal cell carcinoma xenografts.
Ning S; Trisler K; Wessels BW; Knox SJ
Cancer; 1997 Dec; 80(12 Suppl):2519-28. PubMed ID: 9406705
[TBL] [Abstract][Full Text] [Related]
18. Human glioblastoma and carcinoma xenograft tumors treated by combined radiation and imatinib (Gleevec).
Oertel S; Krempien R; Lindel K; Zabel A; Milker-Zabel S; Bischof M; Lipson KE; Peschke P; Debus J; Abdollahi A; Huber PE
Strahlenther Onkol; 2006 Jul; 182(7):400-7. PubMed ID: 16826359
[TBL] [Abstract][Full Text] [Related]
19. Molecular chemotherapy combined with radiation therapy enhances killing of cholangiocarcinoma cells in vitro and in vivo.
Pederson LC; Buchsbaum DJ; Vickers SM; Kancharla SR; Mayo MS; Curiel DT; Stackhouse MA
Cancer Res; 1997 Oct; 57(19):4325-32. PubMed ID: 9331094
[TBL] [Abstract][Full Text] [Related]
20. Therapy for colon carcinoma xenografts with bispecific antibody-targeted, iodine-131-labeled bivalent hapten.
Gautherot E; Bouhou J; Le Doussal JM; Manetti C; Martin M; Rouvier E; Barbet J
Cancer; 1997 Dec; 80(12 Suppl):2618-23. PubMed ID: 9406716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
